Analyst Consensus ?
ConsensusHold37 ratings
Bullish1129.7%
Neutral2054.1%
Bearish616.2%
Molson Coors Beverage Company · TAP · FY2025 Q2 · Calendar Q3 2025
Molson Coors lowers guidance as U.S. demand and aluminum costs weigh
The quarter supports a mixed thesis: resilient core brands, premiumization, non-alcoholic expansion, and intact free-cash-flow guidance provide support, but softer U.S. demand and input-cost volatility weaken the near-term earnings outlook.
Reported Before market openNYSEConsumer Defensive
$6.92B market cap
90quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.05
Consensus $1.83
EPS surprise
+12.0%
Reported versus consensus
Reported revenue
$3.20B
Consensus $3.02B
Revenue surprise
+6.2%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+1.3%
Event window
SPY move
-0.5%
Same window
Abnormal move
+1.8%
Stock minus SPY
Volume
2.4×
Versus trailing sessions
Subsequent drift
+1.2%
Up to 20 sessions
TAPSPY benchmark
Ask FN2 about TAP FY2025 Q2
Transcript, numbers and history already loaded
Why did TAP rise 1.3% after beating EPS estimates in FY2025 Q2?What changed in TAP's guidance and outlook in FY2025 Q2?Give me the bull and bear case for TAP after FY2025 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The main change was a more cautious outlook: management lowered FY2025 top-line and earnings guidance after softer U.S. demand and a sharp Midwest Premium aluminum cost increase. The company continued to emphasize premiumization, innovation, Fever-Tree expansion, and capital returns.
Guidance delta
Lowered FY2025 top-line and earnings guidance, citing softer U.S. demand and Midwest Premium aluminum cost volatility.
Key takeaways
- Management said core brands maintained share, while Coors Banquet posted strong distribution growth.
- Premiumization, innovation, and non-alcoholic expansion remain central to the growth plan.
- Free cash flow guidance remained intact alongside share repurchases and continued capital allocation.
Management priorities
- Advance premiumization across Madri, Peroni, Blue Moon, and other brands.
- Expand the non-alcoholic portfolio, including Fever-Tree distribution.
- Continue innovation, productivity initiatives, disciplined capital allocation, and the CEO succession process.
Follow TAP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$36.91Previous close
$40Low
$53.88Average
$75High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 7, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 5, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 10, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 7, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Aug 7, 2026 |
| Needham | Buy | Buy | Maintain | Aug 7, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 14, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 5, 2026 |
| Barclays | Underweight | Underweight | Maintain | May 4, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| B of A Securities | Underperform | Neutral | Downgrade | Feb 25, 2026 |
| TD Cowen | Hold | Hold | Maintain | Feb 20, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 19, 2026 |
| Roth Capital | Buy | Buy | Maintain | Nov 5, 2025 |
| Jefferies | Hold | Hold | Maintain | Nov 5, 2025 |
| Bernstein | Market Perform | Market Perform | Maintain | Nov 5, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 2, 2025 |
| Wedbush | Neutral | Neutral | Maintain | Nov 6, 2023 |
| Roth MKM | Buy | Buy | Maintain | Oct 4, 2023 |
| CFRA | Buy | Hold | Upgrade | May 2, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Feb 22, 2023 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jan 6, 2023 |
| Bryan Garnier | Sell | Buy | Downgrade | Sep 1, 2022 |
| Redburn Partners | Neutral | Sell | Upgrade | Jul 13, 2022 |
| MKM Partners | Buy | Buy | Maintain | Apr 6, 2020 |
| Guggenheim | Buy | Neutral | Upgrade | Mar 20, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Nov 26, 2019 |
| Redburn | Sell | Neutral | Downgrade | Oct 11, 2019 |
| Bank of America | Underperform | Buy | Downgrade | Jul 15, 2019 |
| Susquehanna | Positive | Positive | Maintain | Aug 2, 2018 |
| Stifel Nicolaus | Hold | Buy | Downgrade | May 17, 2018 |
| Stifel | Hold | Buy | Downgrade | May 17, 2018 |
| Berenberg | Hold | Sell | Upgrade | Feb 8, 2018 |
| Societe Generale | Hold | Buy | Downgrade | May 4, 2017 |
| Nomura | Neutral | Buy | Downgrade | Jun 23, 2015 |
| BTIG Research | Neutral | Buy | Downgrade | Sep 9, 2014 |
| BTIG | Neutral | Buy | Downgrade | Sep 9, 2014 |
| ISI Group | Buy | Neutral | Upgrade | May 16, 2014 |
Named analyst price targets
Upside is calculated against the persisted previous close $36.91. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $45 | $43.04 | +21.9% | Aug 7, 2026 |
| Deutsche Bank | Analyst unavailable | $41 | $41.18 | +11.1% | Jul 22, 2026 |
| UBS | Analyst unavailable | $40 | $40.86 | +8.4% | Jul 16, 2026 |
| Wells Fargo | Analyst unavailable | $41 | $39.27 | +11.1% | Jul 8, 2026 |
| Morgan Stanley | Eric Serotta | $46 | $41.46 | +24.6% | May 4, 2026 |
| Barclays | Analyst unavailable | $41 | $42.14 | +11.1% | May 4, 2026 |
| Deutsche Bank | Steve Powers | $42 | $42.74 | +13.8% | May 1, 2026 |
| Barclays | Analyst unavailable | $43 | $44.54 | +16.5% | Apr 14, 2026 |
| UBS | Analyst unavailable | $52 | $49.21 | +40.9% | Feb 20, 2026 |
| Jefferies | Analyst unavailable | $45 | $48.17 | +21.9% | Feb 19, 2026 |
| Piper Sandler | Analyst unavailable | $45 | $50.81 | +21.9% | Feb 19, 2026 |
| Roth Capital | Analyst unavailable | $58 | $50.81 | +57.1% | Feb 19, 2026 |
| Wells Fargo | Analyst unavailable | $54 | $53.22 | +46.3% | Feb 17, 2026 |
| Barclays | Analyst unavailable | $49 | $49.05 | +32.8% | Jan 16, 2026 |
| BNP Paribas | Analyst unavailable | $40 | $50.64 | +8.4% | Jan 16, 2026 |
| UBS | Analyst unavailable | $50 | $49.64 | +35.5% | Jan 14, 2026 |
| Piper Sandler | Analyst unavailable | $50 | $45.47 | +35.5% | Nov 21, 2025 |
| Wells Fargo | Analyst unavailable | $50 | $46.45 | +35.5% | Nov 19, 2025 |
| Evercore ISI | Robert Ottenstein | $50 | $44.67 | +35.5% | Nov 5, 2025 |
| Roth Capital | Analyst unavailable | $65 | $44.83 | +76.1% | Nov 5, 2025 |
| Jefferies | Kaumil Gajrawala | $48 | $43.67 | +30.0% | Nov 4, 2025 |
| Needham | Analyst unavailable | $54 | $43.31 | +46.3% | Nov 3, 2025 |
| UBS | Peter Grom | $49 | $45.85 | +32.8% | Oct 8, 2025 |
| Piper Sandler | Michael Lavery | $52 | $45.76 | +40.9% | Sep 30, 2025 |
| Roth Capital | William Kirk | $71 | $56.95 | +92.4% | May 20, 2025 |
| Barclays | Lauren Lieberman | $61 | $60.96 | +65.3% | Mar 27, 2025 |
| Wells Fargo | Chris Carey | $74 | $60.03 | +100.5% | Nov 8, 2024 |
| Piper Sandler | Michael Lavery | $59 | $52.1 | +59.8% | Aug 7, 2024 |
| Piper Sandler | Michael Lavery | $57 | $53.07 | +54.4% | Jul 19, 2024 |
| Barclays | Lauren Lieberman | $47 | $53.98 | +27.3% | Jul 18, 2024 |
| Bernstein | Trevor Stirling | $61 | $51.24 | +65.3% | Jul 14, 2024 |
| Evercore ISI | Robert Ottenstein | $68 | $57.26 | +84.2% | Apr 30, 2024 |
| Barclays | Lauren Lieberman | $67 | $67.81 | +81.5% | Apr 12, 2024 |
| Goldman Sachs | Bonnie Herzog | $75 | $66.63 | +103.2% | Apr 9, 2024 |
| Piper Sandler | Michael Lavery | $69 | $67.24 | +86.9% | Mar 22, 2024 |
| Cowen & Co. | Analyst unavailable | $60 | $49.58 | +62.6% | Jan 6, 2023 |
| Deutsche Bank | Steve Powers | $50 | $54.5 | +35.5% | Dec 6, 2022 |
| Bryan Garnier & Co Ltd | Nikolaas Faes | $54 | $51.67 | +46.3% | Sep 1, 2022 |
| Goldman Sachs | Bonnie Herzog | $54 | $55.38 | +46.3% | Jun 28, 2022 |
| Cowen & Co. | Vivien Azer | $55 | $55.86 | +49.0% | Jun 24, 2022 |
| Deutsche Bank | Analyst unavailable | $51 | $54.25 | +38.2% | Apr 27, 2022 |
| MKM Partners | William Kirk | $64 | $49.05 | +73.4% | Feb 24, 2022 |
| Cowen & Co. | Vivien Azer | $50 | $44.5 | +35.5% | Nov 1, 2021 |
| Goldman Sachs | Bonnie Herzog | $42 | $43.42 | +13.8% | Oct 29, 2021 |
| Evercore ISI | Robert Ottenstein | $55 | $43.42 | +49.0% | Oct 29, 2021 |
| Guggenheim | Laurent Grandet | $75 | $48.31 | +103.2% | Jul 29, 2021 |
| Bernstein | Trevor Stirling | $74 | $56.47 | +100.5% | May 24, 2021 |
Track every rating change on TAP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMolson Coors Beverage Company is a global entity engaged in the production, marketing, and sale of a diverse range of beer and other malt-based beverages. Its extensive operations span the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company's product lineup also features flavored malt beverages, craft beers, and convenient ready-to-drink selections. Founded in 1774, the firm, headquartered in Golden, Colorado, was previously known as Molson Coors Brewing Company before officially adopting its current name, Molson Coors Beverage Company, in January 2020.
Historical context
All TAP earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| LW Lamb Weston Holdings, Inc. | FY2027 Q1 · Calendar Q4 2026 | +27.8% | +7.5% | Lamb Weston raises FY2027 outlook as North America volume growth continues |
| MKC McCormick & Company, Incorporated | FY2026 Q3 · Calendar Q4 2026 | +13.9% | -4.9% | McCormick reports strong Q3 growth while U.S. volumes remain soft |
| CAG Conagra Brands, Inc. | FY2027 Q1 · Calendar Q3 2026 | +44.4% | -4.9% | Conagra maintains outlook while increasing brand investment and simplifying SKUs |
| COST Costco Wholesale Corporation | FY2026 Q4 · Calendar Q3 2026 | +3.2% | +2.9% | Costco’s growth broadens as warehouses and digital sales accelerate |
| GIS General Mills, Inc. | FY2027 Q1 · Calendar Q3 2026 | +4.6% | +1.0% | General Mills leans on mix, innovation and e-commerce amid pressure |
| KR The Kroger Co. | FY2026 Q2 · Calendar Q3 2026 | +2.8% | +2.7% | Kroger: Strong digital growth offsets softer sales outlook |
Latest beats and misses
Who reports nextBeat on EPS
- LWFY2027 Q1 · October 6, 2026+27.8% EPS+7.5% move
- RPMFY2027 Q1 · October 6, 2026+1.5% EPS+3.2% move
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
Get the TAP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-07T08:50:44.483847+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-07T08:50:44.480473+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-07. For educational purposes only; not investment advice.